Presented January 20 th by Pharmacy Healthcare Solu7ons, Inc. Don Dietz, R.Ph, MS, Vice President
|
|
- Clyde Lang
- 5 years ago
- Views:
Transcription
1 Presented January 20 th by Pharmacy Healthcare Solu7ons, Inc. Don Dietz, R.Ph, MS, Vice President
2 Disclosures Don Dietz is an employee of Pharmacy Healthcare Solu0ons, Inc. The conflict of interest was resolved by peer review of the slide content. He declares no other conflicts of interest or financial interest in any product or service men0oned in this program, including grants, employment, gips, stock holdings, and honoraria. ASAP s and NCPA s educa0on staff declares no conflicts of interest or financial interest in any product or service men0oned in this program, including grants, employment, gips, stock holdings, and honoraria.
3 Learning Objec7ves 1. Define DIR; explain CMS s original intent and how PBMs have interpreted DIR fees for pharmacy reimbursement. 2. Describe why DIR fees have frustrated retail pharmacies when processing Medicare D claims. 3. Understand how the delay in assessing fees retrospec0vely creates issues for retail pharmacy. 4. Describe how pa0ents can be adversely affected by claw-back fees impac0ng their copayment 5. Review poten0al solu0ons under considera0on to add clarity to the current DIR situa0on.
4 Agenda DIR Fee Defini0on DIR Transparency Pharmacy Profitability Types of DIR Fees Flat-dollar Percentage Performed-based Considera0ons and Poten0al Solu0ons Conclusions & Recommenda0ons
5 CMS s Intent for DIR Fees Pharmacy DIR is embedded in a bigger issue, i.e. CMS wants to eliminate the ability of Part D sponsor and their downstream en00es to hide financial flows from CMS, regardless of their origin. The DIR is a catch all phrase and expansive. Original intent was to allow PBMs and Medicare to share in rebates that insurers received from drug manufacturers under Medicare Part D coverage Health plans/pbm are required to submit an annual DIR report to CMS which is used along with Prescrip0on Drug Event (PDE) data to true up payments by CMS to a Medicare Part D plan for the plan year
6 Direct and Indirect Remunera7on (DIR) Defini7on (CMS 42 CFR ) Actually paid means that the costs must be actually incurred by the Part D sponsor and must be net of any direct or indirect remunera7on (including discounts, charge backs or rebates, cash discounts, free goods con0ngent on a purchase agreement, up-front payments, coupons, goods in kind, free or reducedprice services, grants, or other price concessions or similar benefits offered to some or all purchasers) from any source (including manufacturers, pharmacies, enrollees, or any other person) that would serve to decrease the costs incurred under the Part D plan.
7 DIR Fee Defini7on (cont) Direct and indirect remunera7on includes discounts, chargebacks or rebates, cash discounts, free goods con0ngent on a purchase agreement, up-front payments, coupons, goods in kind, free or reducedprice services, grants, or other price concessions or similar benefits from manufacturers, pharmacies or similar en00es obtained by an intermediary contrac7ng organiza7on with which the Part D plan sponsor has contracted, regardless of whether the intermediary contrac0ng organiza0on retains all or a por0on of the direct and indirect remunera0on or passes the en0re direct and indirect remunera0on to the Part D plan sponsor and regardless of the terms of the contract between the plan sponsor and the intermediary contrac0ng organiza0on.
8 Pharmacy DIR Fees True-up between target reimbursement rate in a PBM/pharmacy agreement and aggregated effec0ve rate realized by a pharmacy True-up between the aggregate MAC/ adjudicated rate and the aggregate contract rate Pay for play in preferred networks Payment mechanism for evalua0ng performance on quality measures
9 Nega7ve DIR Fees Pharmacy receives credit back from a PBM Can occur when a drug s MAC is below its contracted DIR rate Poten0al to protect pharmacies from some overly aggressive MAC prices, but pharmacy may s0ll be losing money on those prescrip0ons Implemented at the GER level vs. individual Rx level
10 DIR Fees, While Legi7mate, Are Not Always Transparent Inadequate disclosure at the 0me of contract execu0on Difficulty reconciling months aper dispensing Pharmacies open in mul0ple networks with major PBMs offering Med D, which leads to addi0onal confusion Quality metric measurements complicated and not easily verifiable Cannot accurately assess Rx sales and profitability DIR fees deducted from 835 Remilance Advice Not on adjudicated claim response
11 DIR Fee Nega7ve Impact on Pharmacy Profitability Walmart Cited lower reimbursement rates in pharmacy as a reason for a quarterly earnings slump Fred s Stores of TN Reduced profit outlook by $30 million, as fees account for 1% of Rx sales Diplomat Gross margin fell from 8% to 6.6%- DIR fees a major factor Stock down 50% Independents 92% of sales are in the pharmacy department; difficult to offset impact of DIR fees in the rest of the store
12 Typical Pharmacy Reimbursement: Single-Source Brand Drug AWP: $300 WAC: $250 Net Cost (WAC - 4%): $240 Reimbursement (AWP - 15% + $1 Dispensing Fee) = $256 Reimbursement - Cost = $256 - $240 = $16 gross profit Cost to dispense around $10 = $6 net profit Pharmacy collects the copayment at the point of sale PBM pays the balance due in days Transac0on complete Profitable Rx for pharmacy
13 DIR Fee Example: Flat-Dollar per Claim AWP: $300 WAC: $250 Net Cost (WAC - 4%): $240 Reimbursement (AWP - 15% + $1 DF) = $256 Reimbursement - Cost - $7 DIR fee = $256 - $240 - $7 = $9 gross profit Cost to dispense of around $10 = -$1 loss DIR fees apply to all prescrip0ons, including discount generics! Pharmacy has a loss that is not seen at dispensing
14 DIR Fee Example: Percentage per Claim AWP: $300 WAC: $250 Net Cost (WAC - 4%): $240 Reimbursement (AWP - 15% + $1 DF) = $256 Reimbursement - Cost - 3% DIR fee = $256 - $240 - $7.68 = $8.32 gross profit Cost to dispense of around $10 = -$1.68 loss Pharmacy has a loss that is not seen at the 0me of dispensing
15 DIR Fee Types & Effects on Pharmacy Flat-Dollar DIR Fee Nega0vely impact retail pharmacies that dispense primarily inexpensive generics $4 lists DIR fee can be greater than the total reimbursement amount For brand/specialty, less impact on profitability Percentage DIR Fee Nega0vely impact specialty pharmacies that dispense high-cost medica0ons E.g. oncology pharmacy Less puni0ve on profitability for low cost generics
16 Performance-Based DIR Fees Incen0vize pharmacy performance on quality metrics to improve pa0ent outcomes Pharmacies that are beler performers get paid more Issues: Some factors are beyond pharmacy control Pa0ent-popula0on (e.g. retail pharmacy located in mental health clinic) Local physician(s) prescribing high-risk medica0ons Small number of pa0ents dicta0ng DIR fees across all Part D plan claims High-quality pharmacy providers have no incen0ve to ac0vely take on chronically ill, at-risk pa0ents because they will be penalized with higher DIR fees
17 Performance-Based DIR Fee Example Performance Category Weight Pharmacy A Performance Pharmacy B Performance ACE/ARB Adherence 20% 5 1 Sta0n Adherence 20% 5 1 Diabetes drug Adherence 20% 5 1 GAP Therapy (sta0n) 25% 5 1 CMR Comple0on Rate 5% 5 1 % High-Risk Meds 5% 5 1 Formulary Compliance 5% 5 1 Weighted Average: 5 1 Performance Score DIR Fee 5 3.5% 4 4.0% 3 4.5% 2 5.0% 1 5.5% DIR Fee is paid as a percentage of the ingredient cost paid 3.5% DIR Fee 5.5% DIR Fee
18 Performance-Based DIR Fee Example Performance Category Pharmacy A Performance Pharmacy B Performance Weighted Average: % DIR Fee 5.5% DIR Fee Impact on Drug Reimbursement Pharmacy A Pharmacy B Ingredient Cost $256 $256 Dispensing Fee Paid $1.00 $1.00 Pa0ent Copay $30 $30 Total Amount Paid $227 $227 DIR Fee $8.96 $14.08 Total Net Reimbursement $ $212.92
19 Beyond Medicare to Commercial DIR fees are specific to Medicare Part D, but a similar process has been introduced in some commercial network agreements Networks Performance networks Discount card programs Fees Creden0aling fees Clawback fees Withhold amounts
20 Discount Card Claw Back Fees PBM contracts with pharmacy at rates less aggressive than funded Rx business, but savings over pharmacy U&C price PBM adjudicates claim, pharmacy collects 100% of adjudicated amount from pa0ent PBM Claws Back a fee (usually fixed dollar) from the pharmacy via withhold on next 835 Remilance Advice Fees vary widely by PBM Pharmacy ar0ficially believes the Rx is more profitable at the 0me of dispensing than aper Claw Back fee
21 Pharmacy Considera7ons Review PBM contracts with greater scru0ny Closely evaluate language on DIR fees Financially assess your network par0cipa0on for unprofitable plans Examine preferred vs. open network par0cipa0on and es0mated pa0ent loss if pharmacy selects open network PSAO contrac0ng op0ons Can I opt out of a nonprofitable agreement? Some PSAOs required pharmacies to take it or leave it when it comes to bundled plans, but others will allow contracts with smaller, op0onal bundles
22 Poten7al Strategies for DIR Fees More clearly define DIR fees in pharmacy network agreements with PBMs Es0mated DIR fees displayed/withheld at the 0me of dispensing to reflect actual reimbursement Greater PBM/Health plan transparency with DIR repor0ng, regulatory strategy Small or no true-up retrospec0vely
23 DIR Fee Proposed Legisla7on Federal legisla0on (H.R and S. 3308) that would prohibit Medicare Part D sponsors/pbms from retroac0vely reducing payment on clean claims submiled by pharmacies under Medicare Part D, therefore elimina0ng retroac0ve pharmacy fees Supported by NCPA and NACDS Not likely to pass in the 114 th Congress, but expected to be re-introduced in the new session
24 Case Study: Medicare Part D Rebates During Non-Coverage (Donut Hole) Manufacturers are required to pay approximately 50% rebate during the donut hole Historically, rebates have been retrospec0ve PBMs could not adjudicate claims with rebates at the 0me of dispensing CMS required rebate considera0ons at the 0me of dispensing, with a reduc0on in pa0ent pay amounts PBMs found a way to es0mate rebates at the 0me of dispensing and reduced pa0ent copays accordingly
25 Performance Networks to expand Expect pharmacy to be asked to take on risk in future pharmacy network designs. How that risk is defined and the impact pharmacy can have on controlling it are key factors to evaluate Unless pharmacy network access is an issue, PBM will become selec0ve in picking the best pharmacy for a network Best today may be lowest price. In the future, it may be outcomes based Poten0al steering pa0ents to beler performing pharmacies
26 Conclusions & Recommenda7ons DIR will con0nue to be a conten0ous issue. Some pharmacy chains have reduced their par0cipa0on in preferred Part D networks as a result. However, others see it as an opportunity to increase Part D marketshare Reduced pharmacy profits will cause addi0onal pharmacy consolida0on In 2014, CMS published Proposed Guidance on Direct and Indirect Remunera0on and Pharmacy Price Concession to implement a process where virtually all price concessions are determined and reasonably approximated at point-of-sale Over two years later, pharmacies should push CMS to finalize and implement the proposed guidelines
27 Ques7ons? Pharmacy Healthcare Solu7ons, Inc. (PHSI) Don Dietz, R.PH, MS Vice President
DIR fees are knocking down pharmacy profits
16 America s PHARMACIST November 2016 DIR fees are knocking down pharmacy profits by Bruce A. Semingson, Pharmacist In 2016, retail pharmacy will pay between $360 million and $2.16 billion in direct and
More informationImplement a definition of negotiated price to include all pharmacy price concessions.
NCPA Analysis of Medicare Part D Pharmacy DIR Fee Reform Policy Proposal and Other Policies Impacting Community Pharmacies in the CMS Proposed Rule, Modernizing Part D and Medicare Advantage to Lower Drug
More informationDIR FEES: WHAT YOU NEED TO KNOW JULY 13, :00 10:00 AM
DIR FEES: WHAT YOU NEED TO KNOW JULY 13, 2017 9:00 10:00 AM ACPE UAN: 0107-9999-17-078-L04-P 0.1 CEU/1.0 hr Activity Type: Knowledge-Based Learning Objectives for Pharmacists: Upon completion of this CPE
More informationDIR: Trends, Issues, and Impending Impacts
DIR: Trends, Issues, and Impending Impacts Lari Harding Vice President, Product Marketing Chris Smith, R.Ph Director, Pharmacy Business Intelligence 1 Disclosures Lari Harding is the Vice President, Product
More informationUnderstanding Pay For Performance and DIR Impact to Pharmacy Reimbursement
Understanding Pay For and DIR Impact to Pharmacy Reimbursement A Public Service Announcement brought to you by Melanie Maxwell, MHP Vice President RxSelect Pharmacy Services Please Don t Shoot the Messenger
More informationPrescription Drug Pricing and Community Pharmacy NALEO Legislative Summit on Health October 21, 2017
Prescription Drug Pricing and Community Pharmacy NALEO Legislative Summit on Health October 21, 2017 Ronna Hauser, PharmD VP Pharmacy Affairs The strength of our numbers NCPA represents America's 22,000+
More informationUnderstanding Pharmacy Benefit Management Services
Understanding Pharmacy Benefit Management Services Peter Cullen VP, Business Development and Strategic Initiatives March 12, 2014 Innovation Session Overview and Learning Objectives Session Overview: Provide
More informationPharmacy Benefit Strategies for Lowering Prescription Drug Costs
Pharmacy Benefit Strategies for Lowering Prescription Drug Costs Mid-sized Retirement and Healthcare Plan Management Conference San Francisco, CA March 17, 2014 Pharmacy Benefit Strategies for Lowering
More informationHow Medication Adherence and Outcomes Are Changing the Business Model
How Medication Adherence and Outcomes Are Changing the Business Model Laura Cranston Executive Director Todd Sega Manager, Payer Relations Lari Harding VP, Strategy & Growth Healthcare Network 3 Session
More informationPharmacy Benefit Strategies for Lowering. Prescription Drug Costs
Pharmacy Benefit Strategies for Lowering Prescription Drug Costs Mid-sized Retirement and Healthcare Plan Management Conference Orlando, FL October 15, 2012 Pharmacy Benefit Strategies for Lowering Prescription
More informationPharmacy Benefit Strategies for Lowering Prescription Drug Costs
Pharmacy Benefit Strategies for Lowering Prescription Drug Costs Mid-sized Retirement and Healthcare Plan Management Conference Chicago, IL June 6, 2012 Pharmacy Benefit Strategies for Lowering Prescription
More informationMedicaid Prescription Drug Payment Reform
Medicaid Prescription Drug Payment Reform Spring 2006 NCSL Health Chairs Meeting John M. Coster, Ph.D., R.Ph. June 10, 2006 1 Community Retail Pharmacy In 2005, there were approximately 56,000 community
More informationINDUSTRY TRENDS IN PHARMACY REIMBURSEMENT
INDUSTRY TRENDS IN PHARMACY REIMBURSEMENT Heather Shouse, Sr. Director, Healthcare Solutions/ Inmar Jon Brumbaugh, Sr. Manager, Product, Healthcare / Inmar Disclosure We have no relationships with commercial
More informationSurvey Analysis of January 2014 CMS Medicare Part D Proposed Rule
Survey Analysis of January 2014 CMS Medicare Part D Proposed Rule Prepared for: Pharmaceutical Care Management Association Prepared by: Stephen J. Kaczmarek, FSA, MAAA Principal and Consulting Actuary
More informationPharmacy Benefit Managers Overview
Pharmacy Benefit Managers Overview A Presentation to the House Health Innovation Subcommittee Mary Alice Nye, Ph.D. Health and Human Services Staff Director, OPPAGA December 6, 2017 Pharmacy Benefit Managers
More informationTHIRD-PARTY PHARMACY RECONCILIATION
THIRD-PARTY PHARMACY RECONCILIATION Billy Caster Sales Solution Expert Inmar Healthcare Network Jon Brumbaugh Sr. Manager, Product Inmar Healthcare Network Session Description A discussion and presentation
More informationCovered Outpatient Drugs Federal Final Rule. Medical Assistance (MA) Program Fee-for-Service (FFS) Pharmacy Reimbursement
Covered Outpatient Drugs Federal Final Rule Medical Assistance (MA) Program Fee-for-Service (FFS) Pharmacy Reimbursement 1 Background On February 1, 2016, the Centers for Medicare and Medicaid Services
More informationMedicare Part D Contract Analysis
Medicare Part D Contract Analysis Presented by: H. Edward Heckman, R.Ph., PAAS National 4:15 p.m. - 5:45 p.m., Tuesday, Ft. Lauderdale, Florida Evaluation # 05-136 This program is approved by NCPA for
More informationMEDICARE PLAN PAYMENT GROUP
DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, Maryland 21244-1850 MEDICARE PLAN PAYMENT GROUP Date: June 23, 2017 To: From: All Part
More informationThe U.S. Healthcare System: How Pharmacy Benefit Managers Impact Prescription Drug Use. Presented by Daniel Tomaszewski Pharmd, PhD
The U.S. Healthcare System: How Pharmacy Benefit Managers Impact Prescription Drug Use Presented by Daniel Tomaszewski Pharmd, PhD 1 Medical Vs. Pharmacy Coverage Medical Insurance Managed by an Insurance
More informationPRESCRIPTION DRUG SPENDING IN THE U.S. HEALTH CARE SYSTEM: AN ACTUARIAL PERSPECTIVE
PRESCRIPTION DRUG SPENDING IN THE U.S. HEALTH CARE SYSTEM: AN ACTUARIAL PERSPECTIVE Moderator Audrey Halvorson, Vice Chairperson, Health Practice Council Presenters Karen Bender, Member, Prescription Drug
More informationProCare Rx - History ProCare Rx founded as a Healthcare Information Technology Company
ProCare Rx - History 1988 ProCare Rx founded as a Healthcare Information Technology Company 1996 Pharmacy Internet Switching Released 2003 ProCare Pharmacy Care Mail Order & Specialty Pharmacy Established
More informationPlunging into PBM Pricing Spread to Create Client Centric Contracts
Plunging into PBM Pricing Spread to Create Client Centric Contracts Scott Haas, Vice President Integrated Healthcare Metrics SIIA 32 nd Annual National Educational Conference & Expo October 2, 2012 Wells
More informationWorldatWork You and Your PBM: Improving Discounts, Fees and Rebates, and Beyond. Kristin Begley, Pharm.D. Principal
WorldatWork You and Your PBM: Improving Discounts, Fees and Rebates, and Beyond Kristin Begley, Pharm.D. Principal Presentation Overview The future of drug trend Prescription drug management levers: Contracting
More informationBERKELEY RESEARCH GROUP. Executive Summary
Executive Summary Within the U.S. healthcare system, the flow of dollars in the pharmaceutical marketplace is a complex process involving a variety of stakeholders and myriad rebates, discounts, and fees
More informationWhat to Expect for Pharmacy Benefits and Drug Cost Trends for 2018 & 2019
What to Expect for Pharmacy Benefits and Drug Cost Trends for 2018 & 2019 Mid-Sized Retirement and Healthcare Plan Management Conference 2018. Innovative Rx Strategies, LLC. All rights reserved. The Ever
More informationApril 8, 2019 VIA Electronic Filing:
April 8, 2019 VIA Electronic Filing: http://www.regulations.gov The Honorable Alex Azar Secretary Department of Health and Human Services 200 Independence Avenue SW, Room 600E Washington, D.C. 20201 Re:
More informationThe Future of 340B. Disclosure
1 The Future of 340B NCPA 2018 Annual Convention Susan Pilch, JD, Senior Vice President, Legal and Advocacy, 340B Health Amanda Gaddy, RPh, Co Founder, Secure340B Disclosure Susan Pilch declares no conflicts
More informationSecurityBlue HMO. Link to Specific Guidance Regarding Exceptions and Appeals
SecurityBlue HMO Conditions and Limitations Potential for Contract Termination Disenrollment Rights and Instructions Exceptions, Prior Authorization, Appeals and Grievances Out-of-Network Coverage Quality
More informationNavigating Medicare 2018
Navigating Medicare 2018 Created and Presented by Barbara Tucciarone Operations Specialist, NORD National Organization for Rare Disorders (NORD) www.rarediseases.org rarediseases.org Welcome The informa7on
More informationPrescription Drugs Spending Distribution and Cost Drivers. Steve Kappel January 25, 2007
Prescription Drugs Spending Distribution and Cost Drivers Steve Kappel January 25, 2007 Introduction Why Focus on Drugs? Compared to other health care spending: Even faster annual growth Higher reliance
More informationTHANK YOU SPONSORS 2
1 THANK YOU SPONSORS 2 How to: Power Up your pharmacy benefit plan Brent Matthews, Benefits Advisor/Principal, TrueNorth Companies Aaron Viertel, Director of Clinical Management, TrueNorth Companies 3
More informationPharmacy Benefit Management in Oncology
Pharmacy Benefit Management in Oncology October 28 th, 2015 Business Health Care Group Protecting the Future of Oncology Care: A Community Conversation Brent Eberle RPh MBA Chief Pharmacy Officer, Navitus
More informationBlueRx PDP. Link to Specific Guidance Regarding Exceptions and Appeals
BlueRx PDP Conditions and Limitations Potential for Contract Termination Disenrollment Rights and Instructions Exceptions, Prior Authorization, Appeals and Grievances Out-of-Network Coverage Quality Assurance
More informationAccess, Quality & Transparency: The Forgotten Issues in the Healthcare Debate Presented at WCIF Benefits Summit April 19, 2017
Access, Quality & Transparency: The Forgotten Issues in the Healthcare Debate Presented at WCIF Benefits Summit April 19, 2017 What s happened? What s next? The ACA remains the Law of the Land for now!
More informationPRESENTATION OF THE QUICK COST AND PLAN FINDER TOOL. For the Connect for Health Colorado Policy Commi4ee July 24, 2017
PRESENTATION OF THE QUICK COST AND PLAN FINDER TOOL For the Connect for Health Colorado Policy Commi4ee July 24, 2017 Agenda Introduc@ons Mee@ng Objec@ve Purpose of the Quick Cost and Plan Finder Tool
More information10/24/13. Christina Bach, MBE, MSW, LCSW, OSW- C Clinical Oncology Social Worker MEDICARE DOES NOT COVER ALL HEALTHCARE COSTS!!!
Christina Bach, MBE, MSW, LCSW, OSW- C Clinical Oncology Social Worker MEDICARE DOES NOT COVER ALL HEALTHCARE COSTS!!! 1 The 9me each year when individuals covered by tradi9onal Medicare or Medicare Advantage
More informationTestimony of Mark Merritt. Pharmaceutical Care Management Association
Testimony of Mark Merritt Pharmaceutical Care Management Association Before the UNITED STATES SENATE COMMITTEE ON HEALTH, EDUCATION, LABOR, AND PENSIONS The Cost of Prescription Drugs: How the Drug Delivery
More informationMoving From PBM to PBA Model
Moving From PBM to PBA Model Lindsey Imada, PharmD Candidate 2016 Midwestern University, Chicago College of Pharmacy Pro Pharma Pharmaceutical Consultants, Inc. Under the preceptorship of Dr. Craig Stern
More informationPharmacy Acquisition Cost and Its Role in Contract Negotiating
Pharmacy Acquisition Cost and Its Role in Contract Negotiating Presented by: Todd Grover Glass Box Analytics August 23, 2017 Understanding Pharmacy Acquisition Cost (AC) Drives Relationship Pairs Pharmacy
More informationPrescription Drug Benefit Plans: A Buyer s Guide. chcf
chcf Prescription Drug Benefit Plans: A Buyer s Guide January 2003 Prescription Drug Benefit Plans: A Buyer s Guide Prepared for CALIFORNIA HEALTHCARE FOUNDATION by Mercer Human Resource Consulting chcf
More informationThe Impact of the Medicare Prescription Drug Legislation on Pharmaceutical Revenues
The Impact of the Medicare Prescription Drug Legislation on Pharmaceutical Revenues Presented By: Jack Rodgers PricewaterhouseCoopers February 27, 2004 P w C Overview of Recent Medicare Act On December
More information3. Prescription Drug Plan Options
3. Prescription Drug Plan Options Overview Electric Boat retirees and spouses have two plan levels for their prescription drug needs in 2018 that can be combined with any of the medical plan alternatives.
More informationSession 64PD, Risk-Sharing Arrangements in Medicare Advantage
Session 64PD, Risk-Sharing Arrangements in Medicare Advantage Presenters: Adam J. Barnhart, FSA, MAAA Hillary H. Millican, FSA, MAAA Simon J. Moody, FSA, MAAA SOA Antitrust Disclaimer SOA Presentation
More informationOverview of Coverage of Drugs Under the Medicaid Medical Benefit
Overview of Coverage of Drugs Under the Medicaid Medical Benefit June 4, 2008 Amanda Bartelme Avalere Health LLC Avalere Health LLC The intersection of business strategy and public policy Medical vs. Pharmacy
More informationPharmacy Program Management: Pitfalls, Challenges, and Best Practices About Solid Benefit Guidance specialty 60,000,000 covered member lives INSIDER
Pharmacy Program Management: Pitfalls, Challenges, and Best Practices October 2, 2017 This presentation contains proprietary information and is not to be reproduced or further distributed without permission
More informationTHIRD PARTY REIMBURSEMENT OF COVERED ENTITIES: MANUFACTURERS PERSPECTIVE
THIRD PARTY REIMBURSEMENT OF COVERED ENTITIES: MANUFACTURERS PERSPECTIVE Donna Lee Yesner Morgan Lewis and Bockius Phone : 202.739.5887 Email: dyesner@morganlewis.com www.morganlewis.com BACKGROUND In
More informationMEDICARE PLAN PAYMENT GROUP
DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, Maryland 21244-1850 MEDICARE PLAN PAYMENT GROUP Date: May 30, 2018 To: From: All Part D
More informationMedicare. Medicare? What does it have to do with me? Alan Farkas, M.S., R.Ph.
Medicare Medicare? What does it have to do with me? Alan Farkas, M.S., R.Ph. 1 Resources Medicare.gov Medicare & You 2018 (PDF version) Optional background reading http://accesspharmacy.mhmedical.com/book.aspx?bookid
More informationToday PBMs control the pharmacy benefits of more than 253 MILLION Americans.
The PBM Story Decades ago, insurance companies expanded their coverage to include prescription drugs. They turned to a new kind of company, a sort of middleman, to process prescription drug claims. For
More informationToday PBMs control the pharmacy benefits of more than 253 MILLION. 3 PBMs. Americans.
The PBM Story Decades ago, insurance companies expanded their coverage to include prescription drugs. They turned to a new kind of company, a sort of middleman, to process prescription drug claims. For
More informationModeling Price Increases and the Effects on Customer Segments
Modeling Price Increases and the Effects on Customer Segments CBI Medicaid Congress May 9, 2017 Jennifer English Director, Pricing, Contracting and Govt Programs, Insmed, Inc. Disclaimer The opinions and
More informationTHE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL INTRODUCED BY EICHELBERGER, ARGALL, RAFFERTY, VULAKOVICH AND BROWNE, MAY 18, 2018 AN ACT
PRINTER'S NO. THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL No. Session of 01 INTRODUCED BY EICHELBERGER, ARGALL, RAFFERTY, VULAKOVICH AND BROWNE, MAY 1, 01 REFERRED TO BANKING AND INSURANCE, MAY 1,
More informationInnovative Strategies for Managing the Rising Cost of Specialty Drugs
Innovative Strategies for Managing the Rising Cost of Specialty Drugs Mid-sized Retirement and Healthcare Plan Management Conference Chicago, IL June 5, 2013 Managing the Rising Cost of Specialty Drugs
More informationImpact of H.R. 1038/S. 413 on CMS Payments Under Part D
At the request of the (NCPA), Wakely Consulting Group, LLC (Wakely) has estimated the financial impact of companion House and Senate bills H.R. 1038/S. 413 ( Improving Transparency and Accuracy in Medicare
More informationContract Summary. OptumRx Administrative Services, LLC
Attachment C Contract Summary OptumRx Administrative Services, LLC Subcontractors This contract includes the following subcontractors or pass through to other providers. Name Service(s) Amount Interpreting
More information2017 Medicare Advantage and Prescription Drug Overview. Module 2
2017 Medicare Advantage and Prescription Drug Overview Module 2 Medicare Advantage Section 1 Proprietary and Confidential Information of UPMC Health Plan Medicare Advantage Three types of Medicare Advantage
More informationSpecialty Pharmacy Trends: Payer and Industry Considerations for Specialty Pharmacies
Specialty Pharmacy Trends: Payer and Industry Considerations for Specialty Pharmacies September 18, 2017 Washington, DC Frier & Levitt, LLC Jonathan E. Levitt, JD Co-Founding Partner jlevitt@frierlevitt.com
More informationSelectHealth Prescriptions
SelectHealth Prescriptions pharmacy benefit management program SM SelectHealth Prescriptions is a full-service Pharmacy Benefit Manager (PBM) that offers transparent pricing, clinically based programs,
More informationMarc Claussen, Chiesi USA, Director, Market Access. Donna White, Chiesi USA, Sr. Director, Contracting and Compliance
Marc Claussen, Chiesi USA, Director, Market Access Donna White, Chiesi USA, Sr. Director, Contracting and Compliance The views/observations expressed in this presentation are the personal views/observations
More informationIntroduction to the US Health Care System. What the Business Development Professional Should Know
Introduction to the US Health Care System What the Business Development Professional Should Know November 2006 1 Understanding of the US Health Care System Evolution of the US health care system to its
More informationThe Management of Specialty Drugs: Opportunities and Challenges
The Management of Specialty Drugs: Opportunities and Challenges Scott Woods Senior Director, Policy PCMA Innovations X April 5, 2016 Specialty Drugs to be Half of Spend by 2018 Forecast PMPM Net Drug
More informationEstablish fair elmbursements
Needed PBM (Pharmacy BeneFit Manager] ReForms - for patients NOW O j.imit purpose nd scope Require price transparency Establish fair elmbursements PBMs started as third party admintsbalors simply chargingan
More informationPHARMACY BENEFIT MANAGER (PBM)
PHARMACY BENEFIT MANAGER (PBM) Presentation by: Pantea Ghasemi, USC Pharm.D. Candidate of 2015 Mentor: Dr. Craig Stern, Pro Pharma Consultants Inc. April 3, 2015 OBJECTIVES 1. Define PBM 2. Discuss Service
More informationAugust 4, The Honorable Charles Rangel, Chairman Committee on Ways and Means United States House of Representatives Washington, D.C.
August 4, 2009 The Honorable Charles Rangel, Chairman Committee on Ways and Means United States House of Representatives Washington, D.C. 20515 The Honorable Henry A. Waxman, Chairman Committee on Energy
More informationFarm Bureau Select Rx 2017 Summary of Benefits January 1, December 31, 2017
P.O. Box 266380 Weston, FL 33326 Farm Bureau Select Rx 2017 Summary of Benefits January 1, 2017 - December 31, 2017 Thank you for your interest in Farm Bureau Select Rx, Our plan is offered by Members
More informationHealth Care Compliance Association: Medicare Part D Compliance Conference
Health Care Compliance Association: Medicare Part D Compliance Conference Pharmacy Audit- What are Part D Plans and PBMs Doing? December 10, 2007 Huron Consulting Services LLC. All rights reserved. Agenda
More informationContract Summary. OptumRx Administrative Services, LLC
Contract Summary OptumRx Administrative Services, LLC Subcontractors This contract includes the following subcontractors or pass through to other providers. Name Service(s) Amount Interpreting Services
More informationThank you for downloading this patient assistance document from NeedyMeds. We hope this program will help you get the medicine you need.
Thank you for downloading this patient assistance document from NeedyMeds. We hope this program will help you get the medicine you need. Did you know that NeedyMeds has thousands of other free resources?
More informationPart D: The New Medicare Prescription Drug Law Implications for Medicaid
Part D: The New Medicare Prescription Drug Law Implications for Medicaid Vernon K. Smith, Ph.D. HEALTH MANAGEMENT ASSOCIATES For State Coverage Initiatives National Meeting Washington, D.C. February 4,
More informationPBM MODEL A A MODEL ACT RELATING TO PHARMACY BENEFIT MANAGERS*
PBM MODEL A A MODEL ACT RELATING TO PHARMACY BENEFIT MANAGERS* Whereas: It is essential to understand the drivers and impacts of prescription drug costs, and transparency is the first step toward that
More informationUnderstanding Your Prescription Program. CCIU Employee Meeting September 7, 2016
Understanding Your Prescription Program CCIU Employee Meeting September 7, 2016 Welcome to FutureScripts! Founded in 2006 Philadelphia presence Strong ties to community and local businesses 68,000 pharmacies
More informationI. PURPOSE. A. The primary objectives of Molina Healthcare s Transition Policy and Procedure are:
I. PURPOSE The purpose of the Policy and Procedure is to ensure necessary continuity of treatment and to provide adequate time and transition process to introduce the enrollee and their prescribing physician
More informationFarm Bureau Essential Rx 2018 Summary of Benefits January 1, December 31, 2018
Farm Bureau Health Plans P.O. Box 266380 Weston, FL 33326 Farm Bureau Essential Rx 2018 Summary of Benefits January 1, 2018 - December 31, 2018 Thank you for your interest in Farm Bureau Essential Rx.
More information2008 Medicare Part D: Pharmacist's Survival Guide. Ronnie DePue, R.Ph., CGP
2008 Medicare Part D: Pharmacist's Survival Guide Ronnie DePue, R.Ph., CGP Objectives At the completion of this program, the participant will be able to: 1. Give an overview of the Medicare Prescription
More informationDisease Management and the Medicare Drug Benefit: Opportunities and Threats for the Pharmaceutical Industry
Disease Management and the Medicare Drug Benefit: Opportunities and Threats for the Pharmaceutical Industry Jeffrey A. Bourret, M.S., R.Ph., FASHP Senior Director, Managed Markets Healthcare Systems Marketing
More informationJanuary 25, 2019 RE: CMS-4180-P. Dear Administrator Verma:
NATIONAL ASSOCIATION OF SPECIALTY PHARMACY 300 New Jersey Ave., Suite 900 Washington, DC 20001 www.naspnet.org January 25, 2019 Ms. Seema Verma, MPH Administrator Centers for Medicare & Medicaid Services
More informationwelcome blueshieldca.com/med_formulary University of California Medicare PPO with Prescription Drug
welcome Welcome to the Blue Shield of California Medicare Rx Plan (PDP) an employer group/union-sponsored Medicare Part D plan for eligible retirees. This plan provides you access to enhanced Medicare
More informationNCPA Summary of CMS Medicaid Covered Outpatient Drugs AMP Final Rule Prepared January NCPA Advocacy at Work
NCPA Summary of CMS Medicaid Covered Outpatient Drugs AMP Final Rule Prepared January 2016 The Centers for Medicare & Medicaid Services (CMS) recently issued a 658-page, oftendelayed, final rule on the
More informationMedicare Modernization Act (MMA)
Medicare Modernization Act (MMA) Julian Whitekus SEAC Conference Charlotte, N.C. November 16 18, 2005 WHAT IS AT STAKE : Projected U.S. Retail Rx Drug Spending 2005 (Total = $223.5 billion) 2006 (Total
More informationThank you for downloading this patient assistance document from NeedyMeds. We hope this program will help you get the medicine you need.
Thank you for downloading this patient assistance document from NeedyMeds. We hope this program will help you get the medicine you need. Did you know that NeedyMeds has thousands of other free resources?
More informationMedicaid Program; Covered Outpatient Drugs; Proposed Rule (CMS-2345-P) NHIA Summary
Medicaid Program; Covered Outpatient Drugs; Proposed Rule (CMS-2345-P) NHIA Summary The Centers for Medicare & Medicaid Services (CMS) on February 2, 2012 published in the Federal Register a proposed rule
More informationBlue Essentials, Blue Advantage HMO SM and Blue Premier SM Provider Manual - Pharmacy
Blue Essentials, Blue Advantage HMO SM and Blue Premier SM Provider Manual - In this Section there are references unique to Blue Essentials, Blue Advantage HMO and Blue Premier. These network specific
More informationKEEPING PRESCRIPTION DRUGS AFFORDABLE: The Value of Pharmacy Benefit Managers (PBMs)
The Texas Association of Health Plans Representing health insurers, health maintenance organizations, and other related health care entities operating in Texas. KEEPING PRESCRIPTION DRUGS AFFORDABLE: The
More information(PDP) 2016 Summary of benefits for our Medicare prescription drug plans (Standard and Enhanced)
(PDP) 2016 Summary of benefits for our Medicare prescription drug plans (Standard and Enhanced) Contract S5540, Plans 002 and 004 January 1, 2016 December 31, 2016 Y0079_7238 CMS Accepted 08312015 U5073g,
More informationThe Declining Value of Payer Access: Defining and improving Rebate Efficiency in the current healthcare landscape
The Declining Value of Payer Access: Defining and improving Rebate Efficiency in the current healthcare landscape Lucas Greenwalt, Senior Principal Amundsen Consulting Prepared for: CBI Gross to Net Boot
More informationPlan Comparison Checklist
Plan Comparison Checklist Date: The chart below should serve as a comprehensive guide for users when comparing health insurance plans during open enrollment. This chart is also used by Compass case managers
More informationThird Quarter 2017 Earnings Conference Call
Third Quarter 2017 Earnings Conference Call Larry Merlo President & Chief Executive Officer Dave Denton Executive Vice President & Chief Financial Officer November 6, 2017 Forward-looking Statements This
More informationMedicare Part D Transition Policy CY 2018 HCSC Medicare Part D
Contract: H0107, H0927, H1666, H3251, H3822, H3979, H8133, H8634, H8554, S5715 Policy Name: Medicare Formulary Transition Purpose: This procedure describes the standard process Health Care Service Corporation
More informationGet the most out of your pharmacy benefit.
Get the most out of your pharmacy benefit. The ins and outs of managing pharmacy costs (and how the right information can lead to big savings). Learn more about the Artemis Platform at: artemishealth.com
More informationMedicare 101. Decluttering the Medicare Confusion. Richard W. Feder
Medicare 101 Decluttering the Medicare Confusion Richard W. Feder May 3, 2018 Today s Presentation What is Medicare Enrollment timing Medicare Insurance Medicare vs. Group/Employer Healthcare Coverage
More informationAHLA. L. Medicare Advantage New Developments and Key Legal Issues. Anne W. Hance McDermott Will & Emery LLP Washington, DC
AHLA L. Medicare Advantage New Developments and Key Legal Issues Anne W. Hance McDermott Will & Emery LLP Washington, DC Institute on Medicare and Medicaid Payment Issues March 26-28, 2014 Recent Developments
More informationInvestor Conference. Health Net Pharmaceutical Services
Investor Conference Health Net Pharmaceutical Services John Sivori President, Health Net Pharmaceutical Services December 13, 2006 Health Net Pharmaceutical Services: What We Do HNPS (HNT s PBM) manages
More informationPharmacy Trend Management
Pharmacy Trend Management Strategies for Maximizing the Value of Your Pharmacy Spend Presenter's Name Presentation Date May 1, 2008 Today s speakers Bridget Eber, Pharm.D. Principal and National Pharmacy
More informationNational Grid Retiree Club Meeting Long Island. October 2, 2017
National Grid Retiree Club Meeting Long Island October 2, 2017 18 Agenda Definitions 2018 Highlights for Management Retirees & Dependents Under Age 65 2018 Highlights for Local 1049 Retirees & Dependents
More informationStanding strong for payers and patients
Standing strong for payers and patients Eric Slusser, EVP, Chief Financial Officer Everett Neville, SVP Supply Chain and Specialty B A N K O F A M E R I C A M E R R I L L L Y N C H H E A LTH C A RE CONFERENCE
More informationSummary of Benefits. Aetna Medicare Rx Costco Plus Plan (PDP) S5810. California. January 1, 2010 to December 31, 2010
January 1, 2010 to December 31, 2010 Summary of Benefits Aetna Medicare Rx S5810 California S5810_D_PE_SB_90712 (08/2009) Visit us www.aetnamedicare.com 1 Summary of Benefits: Aetna Medicare Rx Section
More informationSupport and pass provider status legislation in the House and Senate (H.R. 592/S. 109).
ISSUES Preserve beneficiary access to pharmacy services provided to Medicaid, Medicare and commercially-insured patients as Congress continues to debate health care policy. Support and pass provider status
More informationPrescription Drug Plan Update
Prescription Drug Plan Update Kenyon College May 24, 2018 1 Plan Design Changes effective July 1, 2018 Basic Plan Current Basic Plan 7/1/2018 Premium Plan Current Premium Plan 7/1/2018 Annual Deductible
More informationPharmacy Billing and Reimbursement
FSHP Disclosure Pharmacy Billing and Tara L McNulty RPhT, CPhT I, Tara McNulty, do not have a vested interest in or affiliation with any corporate organization offering financial support or grant monies
More information